Drug Type Small molecule drug |
Synonyms MK 0773 |
Target |
Action modulators |
Mechanism AR modulators(Androgen Receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H34FN5O2 |
InChIKeyGBEUKTWTUSPHEE-JWJWXJQQSA-N |
CAS Registry606101-58-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sarcopenia | Phase 2 | - | 01 Oct 2007 | |
Muscular Atrophy | Phase 2 | United States | - | |
Muscular Atrophy | Phase 2 | Denmark | - | |
Muscular Atrophy | Phase 2 | Finland | - | |
Muscular Atrophy | Phase 2 | France | - | |
Muscular Atrophy | Phase 2 | Italy | - | |
Muscular Atrophy | Phase 2 | Spain | - | |
Muscular Atrophy | Phase 2 | Sweden | - | |
Muscular Atrophy | Phase 2 | United Kingdom | - | |
Osteoporosis | Phase 1 | - | 01 Nov 2005 |
Phase 2 | 170 | (MK-0773) | pmaahfsqrh(hbcinkpllj) = ikzrzbnxfv xyqadbbmoo (acolzzsjbc, 1.09) View more | - | 02 Jul 2012 | ||
Comparator: Placebo (Placebo) | pmaahfsqrh(hbcinkpllj) = nmmhzkreic xyqadbbmoo (acolzzsjbc, 1.29) View more |